The Impact of Central and Peripheral Cyclooxygenase Enzyme Inhibition on Exercise-induced Core Body Temperature Elevations. by Veltmeijer, MT et al.
 
 
The Impact of Central and Peripheral Cyclooxygenase Enzyme Inhibition 1 
on Exercise-induced Core Body Temperature Elevations 2 
 3 
 4 
Matthijs T.W. Veltmeijer, MD1# 5 
Dineke Veeneman, MD1#  6 
Coen C.C.W. Bongers, MSc1  7 
 Mihai G. Netea, MD, PhD2  8 
Jos W. van der Meer, MD, PhD2 9 
Thijs M.H. Eijsvogels, PhD1,3 10 
Maria T.E. Hopman, MD, PhD1 11 
 12 
Radboud Institute for Health Sciences, Departments of 1Physiology and 2Internal Medicine, 13 
Radboud university medical center, Nijmegen, the Netherlands. 3Research Institute for Sports 14 
and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom. 15 
 16 
# Both authors contributed equally to the manuscript. 17 
 18 
 19 
Submission type:   Original Investigation 20 
Running head:   Thermoregulation during exercise 21 
Abstract Word Count: 244 22 
Text-only Word Count:  2863 23 
Figure Count:   1 24 
Table Count:    2 25 
 26 
 27 
 28 
Author for Correspondence:  29 
Prof. Maria T.E. Hopman, Department of Physiology (392), Radboud university medical 30 
center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands, Tel +31 24 36 14 200, Fax +31 31 
24 36 16413, E-mail: Maria.Hopman@Radboudumc.nl 32 
  33 
 
 
ABSTRACT 1 
Purpose: Exercise increases core body temperature (TC) due to metabolic heat production. 2 
However, the exercise-induced release of inflammatory cytokines including interleukin-6 may 3 
also contribute to the rise in TC by increasing the hypothalamic temperature setpoint. We aimed 4 
to investigate whether the exercise-induced increase in TC is partly caused by an altered 5 
hypothalamic temperature setpoint. 6 
Methods: 15 healthy, active male subjects aged 36±14 years were recruited. Subjects 7 
performed submaximal treadmill exercise in 3 randomized test conditions: (1) ibuprofen 400mg 8 
and acetaminophen 1000mg (IBU/APAP), (2) acetaminophen 1000mg (APAP) and (3) a 9 
control condition (CTRL). Acetaminophen and ibuprofen were used to block the effect of 10 
interleukin-6 at a central and peripheral level, respectively. TC, skin temperature and heart rate 11 
were measured continuously during the submaximal exercise tests. 12 
Results: Baseline values of TC, skin temperature and heart rate did not differ across conditions. 13 
Serum interleukin-6 concentrations increased in all three conditions. A significantly lower peak 14 
TC was observed in IBU/APAP (38.8±0.4°C) versus CTRL (39.2±0.5°C, p=0.02), but not in 15 
APAP (38.9±0.4°C) versus CTRL. Similarly, a lower ΔTC was observed in IBU/APAP 16 
(1.7±0.3°C) versus CTRL (2.0±0.5°C, p<0.02), but not in APAP (1.7±0.5°C) versus CTRL. No 17 
differences were observed in skin temperature and heart rate responses across conditions. 18 
Conclusions: The combined administration of acetaminophen and ibuprofen resulted in an 19 
attenuated increase in TC during exercise when compared to a control condition. This 20 
observation suggests that a prostaglandin E2 induced elevated hypothalamic temperature 21 
setpoint may contribute to the exercise-induced rise in TC. 22 
 23 
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INTRODUCTION  1 
Human core body temperature (TC) is strictly regulated by the body’s natural thermostat located 2 
in the hypothalamus. TC is measured by preoptic area neurons and values are compared with 3 
the temperature setpoint, which is typically kept near 36.8±0.4°C1,2. When TC increases beyond 4 
the setpoint temperature, several compensatory mechanisms are activated to release excess 5 
body heat and maintain a proper TC
3,4. 6 
Exercise almost invariably causes TC to rise, as a result of increased metabolic heat 7 
production due to muscle labor3,5,6. Since the hypothalamic temperature setpoint remains 8 
unchanged, a rise in TC will activate heat loss mechanisms including skin vasodilatation and 9 
sweating3. These mechanisms are often insufficient and TC will rise further
7. Another cause for 10 
TC to rise is infection- or inflammation-induced fever, which causes the hypothalamic 11 
temperature setpoint itself to rise. Multiple pro-inflammatory cytokines are released during 12 
infection, including interleukin-1β (IL-1β) and interleukin-6 (IL-6)8. These cytokines stimulate 13 
the enzyme cyclooxygenase (COX) to synthesize prostaglandin E2 (PGE2), which in turn 14 
upregulates the temperature setpoint and via several mechanisms (e.g. vasoconstriction and 15 
shivering) may cause TC to rise
8-11. Antipyretic drugs mainly act by reducing PGE2 synthesis 16 
by inhibiting COX enzyme activity9,10. COX can be inhibited either peripherally (non-steroidal 17 
anti-inflammatory drugs) or centrally in the hypothalamus (acetaminophen)9,12. 18 
Whilst current literature states that metabolic heat production is the sole cause for TC to 19 
rise during exercise, previous authors have also reported that substantial amounts of pro-20 
inflammatory cytokines are released during exercise13,14. It could therefore be hypothesized that 21 
the release of these cytokines during exercise can increase the hypothalamic setpoint, and may 22 
thus be partially responsible for the exercise-induced TC rise.  23 
Recent human studies suggested that drug-induced inhibition of PGE2 synthesis may
15-24 
17 or may not18 attenuate the rise in TC and skin temperature during exercise. These inconsistent 25 
findings may be explained by the different modes of exercise protocols (incremental vs. fixed 26 
intensity), but may also be caused by the fact that these studies inhibited COX-enzyme activity 27 
either centrally (acetaminophen) or peripherally (non-steroidal anti-inflammatory drugs). Since 28 
none of these studies used COX-inhibition via both pathways, to what extent inflammatory 29 
cytokines influence the TC rise during exercise still needs to be elucidated. 30 
The aim of this study was to investigate whether combined inhibition of central 31 
(acetaminophen) and peripheral (ibuprofen) PGE2 synthesis can attenuate the rise in TC during 32 
exercise. We hypothesized that the exercise-induced TC elevations are attenuated in the 33 
combined COX inhibition conditions versus the control condition. 34 
 35 
 36 
METHODS 37 
Fifteen healthy male volunteers unacclimatized to heat were included in this study (Table 1). 38 
Potential subjects were eligible to participate if they were aged between 18-60 years and 39 
performed regular running exercise for at least 1.5 hours per week. After providing written 40 
informed consent, potential subjects were screened for the presence of any exclusion criteria 41 
for using the COX-inhibitors or for using the temperature pill: I) a known hypersensitivity to 42 
acetaminophen or non-steroidal anti-inflammatory drugs II) a peptic ulcer in the medical 43 
history, III) a history of kidney disease, IV) a history of obstructive/inflammatory bowel disease 44 
or surgery (with exception of appendectomy and cholecystectomy), V) having an electrically 45 
implanted device, or VI) scheduled a MRI-scan within 5 days after the test-day. Study 46 
procedures were approved by the Radboud university medical center Ethics Committee and 47 
accorded to the principles of the declaration of Helsinki. 48 
 49 
 
 
Each subject visited our laboratory four times. During the first visit, subjects performed a 1 
maximal treadmill exercise test to determine each subject’s maximal heart rate. Visits 2 to 4 2 
consisted of submaximal exercise tests on a treadmill where running speed was calibrated 3 
individually for each subject’s maximal heart rate. Each submaximal exercise test comprised of 4 
30 minutes continuous running at 85% of the subject’s maximal heart rate, followed by 10 5 
intervals with a 1 minute speed increase of 2km/h and 2 minute speed decrease of 2km/h 6 
compared to the continuous running speed of the first 30 minutes. This exercise protocol was 7 
selected based on pilot measurements within our own department to select the exercise protocol 8 
that elicits the strongest TC rise within one hour. Running speeds of the second and third exercise 9 
test were kept identical to the first exercise test to ensure that stimuli for thermogenesis and 10 
cytokine release were identical across all exercise tests. Using a cross-over design with 11 
randomization of sequences, the following test medication was administered 45 minutes before 12 
the start of each submaximal exercise test. 13 
1. IBU/APAP: Administration of 400mg ibuprofen (IBU) with 100mL of water and 14 
1000mg acetaminophen (APAP) with 100mL of water. 15 
2. APAP: Administration of 1000mg acetaminophen with 100mL of water. An extra 16 
100mL of water was administered as a control substance for ibuprofen. This condition 17 
was added for comparison with previously performed studies using APAP only15,18,19. 18 
3. CTRL: Control condition without inhibition of PGE2 synthesis. Instead, 100mL of water 19 
was administered twice as control substances for acetaminophen and ibuprofen. 20 
The use of the non-steroidal anti-inflammatory drug ibuprofen was chosen because of 21 
pharmacokinetics similar to acetaminophen. Since ibuprofen reaches its maximal plasma 22 
concentration 1-2 hours after ingestion, and acetaminophen reaches its maximal concentration 23 
30 minutes to 2 hours after ingestion, administration of the test medication was timed such that 24 
maximal concentrations were attained 30 to 45 minutes into the exercise bout. The dosage of 25 
both APAP and IBU was based on the Dutch Guidelines for antipyretic treatment20. A minimum 26 
of 3 rest days was required between the submaximal exercise tests to enable full recovery, and 27 
subjects were not allowed to use acetaminophen or NSAIDs for at least 3 days preceding each 28 
measurement. All experiments were performed in the same room at the same temperature 29 
(21°C) and humidity (45%) and the same time of the day to prevent any interference of 30 
environmental conditions or circadian rhythm4. Also, subjects were instructed to consume 31 
500mL of water 2-3 hours before the start of the exercise tests to ensure euhydration at the start 32 
of the exercise bouts21. 33 
 34 
Each subject underwent a maximal exercise test on a treadmill (GTR-3.06, En-Bo 35 
Systems, Zwolle, Netherlands) using the Bruce protocol. Oxygen consumption was measured 36 
using a calibrated gas exchange analyser (Quark CPET, Cosmed, Italy) with a breathing mask. 37 
Heart rate was monitored using a Cosmed HR monitor (Cosmed, Italy). Capillary blood lactate 38 
levels were measured (Lactate Pro, Arkray, Kyoto, Japan) before and after the maximal exercise 39 
test as an indicator for achieving maximal exercise (>8 mmol/L). Other indicators for maximal 40 
exercise were a plateau in the VO2-curve, a respiratory exchange ratio ≥1.1, and a maximal 41 
heart rate ≥95% of the age-predicted maximum. Subjects had to meet 3 out of the 4 42 
aforementioned criteria to achieve maximal exercise. 43 
The subjects were instructed to ingest a telemetric temperature pill (CorTemp, HQ Inc, 44 
Palmetto Fl, USA) 6 hours prior to each submaximal exercise test to assure stomach passage 45 
and exclude interference from fluid or food ingestion22. Using an external recorder TC was 46 
recorded every 20 seconds and averaged per minute. This method is known to be valid and safe, 47 
and was described in detail previously23. 48 
The skin temperature (TSK) was measured during each test using individual skin 49 
temperature sensors (iButtons, Maxim Integrated, San Jose, CA, USA). TSK was measured 50 
 
 
every 30 seconds with a resolution of 0.0625°C. Using the ISO 9886 norm, 8 different iButtons 1 
were attached to the skin: on the forehead, right scapula, left thorax, right upper arm, left lower 2 
arm, left hand, right upper leg and left calf. Mean TSK was calculated from a standard area 3 
weighing factors24, and averaged per minute. 4 
To compare the exercise intensity during the submaximal exercise tests the heart rate 5 
was measured in beats per minute using a chest band system (Polar RS800, Oy, Kempele, 6 
Finland). The heart rate was measured every 15 seconds and averaged per minute. 7 
To assess sweat losses, body weight was measured immediately before and after each exercise 8 
bout, after subjects towelled off sweat and with subjects wearing shorts and underwear only 9 
(Seca 888 scale, Hamburg, Germany). Relative body weight changes were calculated to assess 10 
the hydration status of subjects. 11 
To compare the stimulus for PGE2 synthesis in every test condition a venous blood 12 
sample was taken to measure the concentration of IL-6 at baseline (before taking the 13 
medication) and directly after completing the exercise test. A 10mL K3EDTA vacutainer tube 14 
was used to collect the blood sample and was immediately after collection centrifuged at 4°C 15 
and 3600 rpm for 12 minutes. All samples were subsequently stored at -80°C until further 16 
analysis. All blood samples were analysed on the same day after completing all experimental 17 
tests. A commercial IL-6 ELISA kit (Pelipair human IL-6 ELISA kit, Sanquin, Amsterdam, the 18 
Netherlands) was used for determining IL-6 concentrations. The detection limit of the IL-6 19 
ELISA kits was 3 pg/ml. 20 
Rate of perceived exertion (RPE) was measured every 6 minutes using the BORG-21 
scale25. This scale ranges from 6-20 with 6 being very mild and 20 the most strenuous exercise. 22 
Furthermore we asked subjects to rate Thermal Sensation and Thermal Comfort every 6 23 
minutes. Thermal Sensation measures the temperature perception of the subject with a scale 24 
ranging from -3 being really cold to +3 being really hot. Thermal Comfort is a measure of how 25 
comfortable the temperature feels to the subject ranging from -4 being very comfortable to +4 26 
being very uncomfortable26. 27 
 28 
All data are presented as mean ± standard deviation unless indicated otherwise. 29 
Statistical analyses were conducted using SPSS version 20 (IBM SPSS version 20.0, Armonk, 30 
NY, USA). Changes over time (baseline vs. peak) and between conditions (IBU/APAP/CTRL) 31 
were analysed using a within-subject repeated-measures ANOVA. Delta (Δ) TC and TSK were 32 
determined as the difference between maximal value and baseline value. Group differences at 33 
the same time point (e.g. ambient temperature, baseline or peak Tc) were analysed using a 34 
within-subject one-way ANOVA.  Due to the fact that some baseline values of the IL-6 35 
concentrations were below the detection limit, a logistic regression analysis was performed to 36 
test whether more values were above the detection limit post-exercise compared to baseline. In 37 
case of a significant outcome a post-hoc Bonferroni test was applied. The level of significance 38 
was set at p≤0.05.  39 
 40 
 41 
RESULTS  42 
All subjects successfully completed the maximal and submaximal exercise tests (Table 1). All 43 
subjects completed the entire study protocol within 4 weeks. Room temperature (IBU/APAP 44 
21.1±0.9°C, APAP 21.3±0.6°C, CTRL 21.1±1.0°C, p=0.80) and humidity (IBU/APAP 45 
42.3±9.1%, APAP 45.0±11.0%, CTRL 43.5±7.5%, p=0.60) were similar across the three test 46 
conditions. VO2 MAX was 61.7 ± 9.9 mL/min/kg. Maximal heart rate was 186 ± 11 bpm. No 47 
adverse events occurred and all subjects met the criteria for achieving maximal exercise. 48 
 49 
 
 
TC was similar at baseline across the three conditions (IBU/APAP 37.1±0.2°C, APAP 1 
37.3±0.2°C, CTRL 37.1±0.2°C; p=0.16). TC increased significantly over time (p<0.001), and a 2 
significant time*condition interaction was found (p=0.048). Maximum TC was significantly 3 
lower in the IBU/APAP condition compared to the CTRL condition (IBU/APAP 38.8±0.4°C 4 
versus CTRL 39.2±0.5°C; p=0.02) but not between APAP and CTRL (APAP 38.9±0.4°C). A 5 
lower ΔTC was observed in the IBU/APAP condition versus the CTRL condition (IBU/APAP 6 
1.7±0.3°C versus CTRL 2.0±0.5°C; p=0.042; Figure 1A). ΔTC did not differ between APAP 7 
and CTRL (APAP 1.7±0.5°C). 8 
 9 
TSK was similar at baseline in all three conditions (IBU/APAP 31.8±0.4°C, APAP 10 
32.0±0.4°C, CTRL 31.8±0.5°C; p=0.23). TSK increased significantly over time in all conditions 11 
(p<0.001), though no differences across conditions (p=0.42) or time*condition (p=0.52) were 12 
found. Also, there were no differences in maximum TSK (IBU/APAP 34.2±0.6°C, APAP 13 
34.3±0.6°C, CTRL 34.2±0.6°C; p=0.95) or ΔTsk (IBU/APAP 2.3±0.6°C, APAP 2.3±0.7°C, 14 
CTRL 2.4±0.6°C; p=0.53) across conditions (Figure 1B). 15 
 16 
Before the start of the sub-maximal exercise tests, heart rate was similar across 17 
conditions (IBU/APAP 106±15 bpm, APAP 107±12 bpm, CTRL 102±15 bpm; p=0.51). Heart 18 
rate increased significantly over time in all conditions (p<0.001), though no significant 19 
condition*time interaction occurred (p=0.28). No differences in maximal heart rate (IBU/APAP 20 
168±10 bpm, APAP 170±10 bpm, CTRL 172±6 bpm; p=0.35) or delta heart rate (IBU/APAP 21 
64±16 bpm, APAP 64±19 bpm, CTRL 69±14 bpm; p=0.28) were observed across conditions 22 
(Figure 1C). 23 
 24 
The prevalence of IL-6 concentration in serum exceeding the level of detection 25 
(>3mmol/L) was low across all conditions at baseline (IBU/APAP n=1 (7%; range 7), APAP 26 
n=3 (20%; range 3-24), CTRL n=1 (7%; range 4), whilst a substantially higher amount of 27 
samples post-exercise showed levels exceeding the level of detection (IBU/APAP n=10 (67%; 28 
range 3-8), APAP n=7 (47%; range 4-11), CTRL n=12 (80%; range 3-10)). No significance 29 
levels could be determined to compare pre- versus post-exercise values due to the low number 30 
of samples being below the level of detection pre-exercise. 31 
 32 
Maximal RPE and average RPE were not different among conditions (Table 2). No 33 
significant differences were observed among conditions in maximal and average thermal 34 
comfort. There were no differences among conditions in maximal and average thermal 35 
sensation. Body weight change was similar across all conditions (Table 2). 36 
 37 
 38 
DISCUSSION 39 
The aim of this study was to investigate the effect of combined inhibition of central and 40 
peripheral PGE2 synthesis on the rise in TC during exercise. We found a significantly lower 41 
maximal TC with combined inhibition (IBU/APAP) compared to CTRL, whilst central 42 
inhibition only (APAP) was not different from CTRL. No significant differences in maximal 43 
TSK, heart rate, body weight change and RPE were observed across conditions. These results 44 
suggest that exercise-induced PGE2 synthesis may impact on the thermoregulatory setpoint and 45 
may therefore contribute to the increase in TC during exercise in humans. 46 
The present study was performed under similar environmental circumstances in all three test 47 
conditions. Furthermore the intensity of exercise was identical across conditions, ensuring equal 48 
thermogenesis and release of pro-inflammatory cytokines was identical during each test. The 49 
measurements were performed in moderate temperatures since we wanted to replicate 50 
 
 
conditions similar to those typically encountered in recreational running. The randomization of 1 
all three conditions rules out a potential training effect. Although significance levels could not 2 
be determined, IL-6 levels showed a similarly low prevalence of values exceeding the level of 3 
detection pre-exercise, as well as a substantially higher prevalence exceeding the level of 4 
detection post-exercise. Whilst no significance levels could be determined for this difference, 5 
it does suggest that elevated IL-6 levels during exercise posed as stimulus for PGE2 production 6 
across all conditions in line with previous literature13,14. Also, the lack of differences in body 7 
weight loss across conditions out rules any influence by differences sweat losses. Lastly, the 8 
study protocol was not blinded since humans are unable to (sub)consciously alter their body 9 
temperature and since the exercise protocols were kept identical (i.e. identical metabolic heat 10 
production during each exercise test). Blinding was therefore not expected to alter our results. 11 
 12 
A significantly lower maximum TC and ΔTC were found in the IBU/APAP compared to the 13 
CTRL condition, but not between the APAP and CTRL condition. These observations support 14 
our hypothesis and suggest a superior effect of simultaneous central and peripheral COX 15 
inhibition, although a similar effect of central inhibition and combined inhibition cannot be 16 
completely ruled out given the similar delta TC between IBU/APAP and APAP. Whilst we did 17 
not identify a significant effect of APAP alone, previous authors did15,16. Possible explanations 18 
for this may be differences in the exercise protocol15,16, ambient conditions15,16 or training 19 
status16. The primary site of action for acetaminophen is the inhibition of PGE2 synthesis in the 20 
brain through the inhibition of the COX-1 and COX-2 enzyme9,27. Ibuprofen is a non-selective 21 
cyclooxygenase inhibitor in the NSAID group and the mechanism of action is lowering PGE2 22 
by directly inhibiting COX-1 and COX-2 enzyme activity peripherally9. Because 23 
acetaminophen and ibuprofen act as COX-enzyme inhibitors on a central respectively a 24 
peripheral level they maximally inhibit PGE2 synthesis produced by exercise-induced IL-6 25 
release. Whilst COX has been shown to not affect forearm sweating28,  a clinical study 26 
suggested that the combined therapy of acetaminophen and ibuprofen is more effective in 27 
lowering TC during fever
29. The present study expands this observation to an exercise setting. 28 
Especially since previous human studies that used drug-induced inhibition of PGE2 synthesis 29 
during exercise15-18 used either central or peripheral COX inhibitors and reported conflicting 30 
results. Our study adds to this that the combination of central and peripheral COX inhibition is 31 
more effective than central COX inhibition only. This may also suggest that circulating 32 
prostaglandins from the periphery may also influence TC, in addition to centrally synthesized 33 
prostaglandins. Moreover, exercise-induced PGE2 synthesis impacts on the thermoregulatory 34 
setpoint and thus contributes to the increase in TC. Whilst the difference of maximum TC 35 
between all three conditions is small, we believe the difference is still relevant given the 36 
competitive nature of exercise in which even the smallest difference is important. 37 
 38 
When TC rises, mechanisms are activated to dissipate heat to the surroundings. One of these 39 
mechanisms is an elevated skin blood flow. Vasodilatation causes skin blood flow to increase 40 
so that warmer blood from the core is transported to the periphery and TSK will rise
3. One 41 
previous study showed a lower TSK when acetaminophen was administered in comparison to a 42 
placebo16. Simultaneously they found a lower TC in the acetaminophen group. Three other 43 
studies that investigated acetaminophen or a non-steroidal anti-inflammatory drug did not find 44 
a difference in TSK
15,17,18. We did not find any differences in TSK across conditions either. 45 
Ambient temperatures were similar across conditions and have thus affected TSK in a similar 46 
way. Whilst changes in TC do affect TSK, it has also been suggested that when TC exceeds the 47 
value of 38°C the increase in skin blood flow during exercise is attenuated30. As all study 48 
participants demonstrated a maximum TC >38°C, this might explain the observation that TSK 49 
did not differ across conditions in the present study. 50 
 
 
 1 
Our main goal was to investigate whether an altered setpoint plays a role in the rise in TC during 2 
exercise for a better understanding of thermoregulation during exercise in humans. The 3 
combined central and peripheral COX blockade using acetaminophen and ibuprofen resulted in 4 
a slightly but significantly lower maximal TC (0.3°C) compared to no COX blockade at all. This 5 
suggests that the exercise-induced rise in TC may be partially explained by an elevated 6 
temperature setpoint. The limited TC difference makes it uncertain whether the elevated setpoint 7 
impacts athletic performance, though further research into this is needed. Whilst we would not 8 
recommend chronic use of acetaminophen and ibuprofen during exercise to lower TC given the 9 
potential adverse effects such as kidney damage and gastro-intestinal problems, occasional use 10 
might be beneficial for athletes to slightly reduce their TC at times of high thermal stress and 11 
improve exercise performance16,31. 12 
 13 
 14 
Practical Applications: 15 
 Combined blockade of prostaglandin E2 production both centrally (acetaminophen) and 16 
peripherally (ibuprofen) resulted in a slightly but significantly lower maximal core body 17 
temperature during one hour of strenuous running exercise. 18 
 This finding suggests that part of the rise in core body temperature during exercise might 19 
be caused by an altered hypothalamic temperature setpoint. The remainder of the 20 
temperature rise is still attributable to metabolic heat production. 21 
 Whilst chronic use of COX inhibitors is not recommended, occasional use of 1000mg 22 
acetaminophen and/or 400mg ibuprofen might be beneficial for athletes to reduce the 23 
exercise-induced TC at times of high thermal stress. 24 
 25 
Conclusion 26 
In conclusion, combined administration of acetaminophen and ibuprofen results in an 27 
attenuated maximal TC during exercise compared to a control condition. This suggests that 28 
besides the production of metabolic heat, the release of pro-inflammatory cytokines contributes 29 
to an elevated hypothalamic thermoregulatory setpoint via increased levels of PGE2. Our results 30 
suggest that an upregulated hypothalamic temperature setpoint might partially be responsible 31 
for the exercise-induced TC rise. 32 
 33 
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Figure legend 1 
 2 
 3 
 4 
Figure 1 A: Core Body Temperature (TC) during exercise during the exercise bouts. Maximum 5 
TC and ΔTC are significantly lower in the IBU/APAP condition compared to the CTRL 6 
condition. B: Skin Temperature (TSK) during the exercise bouts. No significant differences were 7 
observed in maximum TSK and ΔTSK. There was a significant interaction effect, but no effect 8 
 
 
for condition. C: Heart Rate (HR) during the exercise bouts. No significant differences were 1 
observed in maximum HR and ΔHR. There was a significant interaction effect, but no effect 2 
for condition. For readability purposes, the error bars are not visualized on the same time points. 3 
† = p<0.05. 4 
  5 
 
 
Table 1. Subject characteristics and results of the maximal exercise test.  1 
 2 
Characteristic  Range 
Age (yrs)  36 ± 14 21 - 59 
Body Mass Index (kg/m2) 22.8 ± 1.9 19.2 - 27.4 
Height (cm) 181 ± 8 170 - 190 
Training time (hours / week) 4.4 ± 2.6 1.5 - 11 
Maximal Heart Rate (bpm) 186 ± 11 159 - 197 
VO2max (mL/min/kg) 61.7 ± 9.9 43.1 - 78.0 
Lactate pre-test (mmol/L) 1.5 ± 0.9 0.8 - 4.4 
Lactate post-test (mmol/L) 13.9 ± 3.2 7.9 - 18.5 
 
 3 
  4 
 
 
Table 2. Rate of perceived exertion, thermal comfort, thermal sensation scores and body weight 1 
change during the submaximal exercise tests.  2 
 3 
 IBU/APAP APAP CTRL p-value 
RPE max (au) 13.9 ± 1.8 13.2 ± 2.2 13.2 ± 1.6 0.36 
RPE average (au)  11.9 ± 1.0 11.6 ± 1.6 11.8 ± 1.2 0.57 
Thermal Comfort max (au)  1.7 ± 1.2 1.7 ± 1.1 1.7 ± 1.1 0.97 
Thermal Comfort average (au)  0.8 ± 1.1 0.7 ± 1.0 0.5 ± 0.9 0.16 
Thermal Sensation max (au)  1.9 ± 0.8 1.9 ± 0.8 2.0 ± 0.6 0.86 
Thermal Sensation average (au)  1.3 ± 0.5 1.3 ± 0.6 1.4 ± 0.6 0.88 
Body weight change (%) -1.6 ± 0.3 -1.5 ± 0.2 -1.5 ± 0.3 0.66 
RPE: Rate of Perceived Exertion. IBU/APAP: peripheral and central COX inhibition by ibuprofen and 4 
acetaminophen. APAP: central COX inhibition by acetaminophen. CTRL: control condition. AU: arbitrary units. 5 
 6 
